Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Current Liabilities -----

What is the latest Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Current Liabilities ratio of GLENMARK PHARMACEUTICALS is - based on Mar2026 Consolidated results.
Year Current Liabilities
Mar2026-
Mar2025-
Mar2024-
Mar2023-
Mar2022-

How is Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Current Liabilities % Change
Mar2026 -
0
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 - -

Compare Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹73,761.4 Cr -1.9% 16.8% 45.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,688.0 Cr -2% 6% 9.6% Stock Analytics
DIVIS LABORATORIES ₹295,080.0 Cr -4% 22.9% 75.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,677.0 Cr -1.8% 1.8% 21.9% Stock Analytics
DR REDDYS LABORATORIES ₹115,852.0 Cr -0.4% 13.1% 13.7% Stock Analytics
CIPLA ₹111,731.0 Cr -0.9% 4.5% -8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.9%

16.8%

45.4%

SENSEX

1.8%

11.1%

-1.6%


You may also like the below Video Courses